MORGAN STANLEY PLC/CALL/MERCK & CO./110/0.1/17.01.25 Share Price

Warrant

DE000MB1WWU6

Real-time Bid/Ask 05:00:01 08/07/2024 pm IST
1.92 EUR / 1.95 EUR +5.16% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./110/0.1/17.01.25
Current month-14.02%
1 month-14.81%
Date Price Change
08/24/08 1.91 +3.80%
05/24/05 1.84 +2.22%
04/24/04 1.8 -3.74%
03/24/03 1.87 -8.33%
02/24/02 2.04 -1.45%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 01:39 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB1WWU
ISINDE000MB1WWU6
Date issued 30/12/2022
Strike 110 $
Maturity 17/01/2025 (194 Days)
Parity 10 : 1
Emission price 2.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.63
Lowest since issue 0.54
Spread 0.03
Spread %1.54%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus